VIKING GLOBAL INVESTORS LP 13D and 13G filings for NewAmsterdam Pharma Company N.V.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 10:12 am Purchase | 2023-12-31 | 13G | NewAmsterdam Pharma Company N.V. NAMS | VIKING GLOBAL INVESTORS LP | 8,024,565 9.700% | 1,500,000 (+22.99%) | Filing |
| 2023-06-20 4:30 pm Purchase | 2023-06-07 | 13G | NewAmsterdam Pharma Company N.V. NAMS | VIKING GLOBAL INVESTORS LP | 6,524,565 7.980% | 6,524,565 (New Position) | Filing |